ADVFN US – Market Content Editor
-

Ford Recalls 175,000 Vehicles in the U.S. Due to Moonroof Deflector Safety Risk
Ford Motor Company (NYSE:F) has issued a recall for nearly 175,000 vehicles in the United States after discovering a potential issue with moonroof wind deflectors that may become detached while driving, according to a notice released by the National Highway Traffic Safety Administration (NHTSA) on Wednesday. The recall covers multiple models across Ford’s lineup, including…
-

Thermo Fisher Set to Acquire Clario in $10 Billion Deal – FT
Thermo Fisher Scientific (NYSE:TMO), a leading player in the life sciences industry, is reportedly close to finalizing a deal to purchase clinical-trial technology company Clario for roughly $10 billion, according to the Financial Times, which cited sources familiar with the matter. An official announcement could come as early as Wednesday, provided that final negotiations are…
-

Stellantis Accelerates Toward Autonomous Future with Nvidia, Uber, and Foxconn Partnership
Stellantis N.V. (NYSE:STLA) has taken another major step into the autonomous driving arena, unveiling a new collaboration with Nvidia Corporation (NASDAQ:NVDA), Uber Technologies Inc. (NYSE:UBER), and Foxconn Technology Group (USOTC:FXCOF) to develop and deploy Level 4 autonomous vehicles for global robotaxi services. The move follows the automaker’s recent alliance with Pony.ai, signaling Stellantis’ accelerating push…
-

Markets on Edge: Tech Giants’ Earnings, Fed Rate Decision, and Trump–Xi Talks in Focus
Global investors face a pivotal day on Wednesday, with a trio of major catalysts poised to shape sentiment — a Federal Reserve rate cut, a flood of mega-cap tech earnings, and President Donald Trump’s diplomatic visit to Asia, which could lead to a breakthrough meeting with China’s Xi Jinping. At 03:38 ET, Dow futures slipped…
-

Gold Steadies Near Three-Week Low as Traders Await Fed Rate Cut and Trade Sentiment Improves
Gold prices were little changed on Wednesday, hovering close to three-week lows, as easing U.S.-China trade tensions and anticipation of a Federal Reserve rate decision kept investors on the sidelines. At 01:40 ET (05:40 GMT), spot gold was up 0.2% to $3,957.42 per ounce, while U.S. gold futures edged down 0.1% to $3,977.76. The metal…
-

Oil Prices Gain as U.S.-China Meeting Fuels Optimism and Inventories Decline
Oil prices moved higher on Wednesday, lifted by a larger-than-expected draw in U.S. crude inventories and renewed optimism ahead of a high-profile meeting between the leaders of the United States and China — the world’s top two oil consumers. By 07:45 GMT, Brent crude futures rose 22 cents, or 0.34%, to $64.62 a barrel, while…
-

U.S. Stocks Fluctuate But Close At New Record Highs
Stocks fluctuated over the course of the trading session on Tuesday but largely maintained a positive bias and ended the day mostly higher. The major averages added to the strong gains posted during Monday’s session, once again reaching new record closing highs. The major averages pulled back off their highs in late-day trading but still…
-

Microsoft stock jumps after new OpenAI deal values stake at $135 billion
Microsoft (NASDAQ:MSFT) shares climbed 4% Tuesday morning after the company unveiled a new definitive agreement with OpenAI that values its stake in the AI developer at approximately $135 billion. The updated deal expands on the companies’ partnership established in 2019. Microsoft now holds roughly 27% ownership in OpenAI Group PBC on an as-converted diluted basis…
-

TEN Holdings Inc stock surges after signing reseller deal with Xcyte Digital Corporation
TEN Holdings Inc (NASDAQ:XHLD) shares soared 60% in premarket trading Tuesday after the company announced a three-year digital reseller agreement with Xcyte Digital Corporation. According to a regulatory filing, the deal grants TEN Holdings the right to integrate, bundle, and resell Xcyte’s conferencing solutions to both existing and future customers. The contract runs for an…
-

Quoin Pharmaceuticals Ltd stock climbs on encouraging pediatric trial results
Quoin Pharmaceuticals Ltd (NASDAQ:QNRX) shares rose 2.2% in premarket trading Tuesday after the late-stage biopharmaceutical company announced positive 9-month clinical results from its pediatric Netherton Syndrome trial and confirmed the enrollment of three additional patients. The company reported that the first pediatric patient in the study achieved fully healed skin after nine months of treatment…